BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 17457046)

  • 1. Velafermin improves gastrointestinal mucositis following irinotecan treatment in tumor-bearing DA rats.
    Gibson RJ; Stringer AM; Bowen JM; Logan RM; Yeoh AS; Burns J; Alvarez E; Keefe DM
    Cancer Biol Ther; 2007 Apr; 6(4):541-7. PubMed ID: 17457046
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palifermin reduces diarrhea and increases survival following irinotecan treatment in tumor-bearing DA rats.
    Gibson RJ; Bowen JM; Keefe DM
    Int J Cancer; 2005 Sep; 116(3):464-70. PubMed ID: 15800945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Establishment of a single-dose irinotecan model of gastrointestinal mucositis.
    Gibson RJ; Bowen JM; Alvarez E; Finnie J; Keefe DM
    Chemotherapy; 2007; 53(5):360-9. PubMed ID: 17713326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis.
    Logan RM; Gibson RJ; Bowen JM; Stringer AM; Sonis ST; Keefe DM
    Cancer Chemother Pharmacol; 2008 Jun; 62(1):33-41. PubMed ID: 17703303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum-derived bovine immunoglobulin/protein isolate in the alleviation of chemotherapy-induced mucositis.
    Bateman E; Weaver E; Klein G; Wignall A; Wozniak B; Plews E; Mayo B; White I; Keefe D
    Support Care Cancer; 2016 Jan; 24(1):377-385. PubMed ID: 26081596
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of Saccharomyces boulardii on reducing irinotecan-induced intestinal mucositis and diarrhea.
    Sezer A; Usta U; Cicin I
    Med Oncol; 2009; 26(3):350-7. PubMed ID: 19067257
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amitriptyline prevents CPT-11-induced early-onset diarrhea and colonic apoptosis without reducing overall gastrointestinal damage in a rat model of mucositis.
    Fakiha K; Coller JK; Logan RM; Gibson RJ; Bowen JM
    Support Care Cancer; 2019 Jun; 27(6):2313-2320. PubMed ID: 30350190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemotherapy-induced diarrhea is associated with changes in the luminal environment in the DA rat.
    Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Burns J; Keefe DM
    Exp Biol Med (Maywood); 2007 Jan; 232(1):96-106. PubMed ID: 17202590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Velafermin (rhFGF-20) reduces the severity and duration of hamster cheek pouch mucositis induced by fractionated radiation.
    Ara G; Watkins BA; Zhong H; Hawthorne TR; Karkaria CE; Sonis ST; Larochelle WJ
    Int J Radiat Biol; 2008 May; 84(5):401-12. PubMed ID: 18464069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Irinotecan- and 5-fluorouracil-induced intestinal mucositis: insights into pathogenesis and therapeutic perspectives.
    Ribeiro RA; Wanderley CW; Wong DV; Mota JM; Leite CA; Souza MH; Cunha FQ; Lima-Júnior RC
    Cancer Chemother Pharmacol; 2016 Nov; 78(5):881-893. PubMed ID: 27590709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The reduction of oxidative stress by nanocomposite Fullerol decreases mucositis severity and reverts leukopenia induced by Irinotecan.
    Arifa RDN; Paula TP; Madeira MFM; Lima RL; Garcia ZM; Ÿvila TV; Pinho V; Barcelos LS; Pinheiro MVB; Ladeira LO; Krambrock K; Teixeira MM; Souza DG
    Pharmacol Res; 2016 May; 107():102-110. PubMed ID: 26987941
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile.
    Stringer AM; Gibson RJ; Bowen JM; Logan RM; Ashton K; Yeoh AS; Al-Dasooqi N; Keefe DM
    Int J Exp Pathol; 2009 Oct; 90(5):489-99. PubMed ID: 19765103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation.
    Lima-Júnior RC; Figueiredo AA; Freitas HC; Melo ML; Wong DV; Leite CA; Medeiros RP; Marques-Neto RD; Vale ML; Brito GA; Oriá RB; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2012 Apr; 69(4):931-42. PubMed ID: 22101361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer.
    Gibson RJ; Bowen JM; Inglis MR; Cummins AG; Keefe DM
    J Gastroenterol Hepatol; 2003 Sep; 18(9):1095-100. PubMed ID: 12911669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of cytokines (TNF-alpha, IL-1beta and KC) in the pathogenesis of CPT-11-induced intestinal mucositis in mice: effect of pentoxifylline and thalidomide.
    Melo ML; Brito GA; Soares RC; Carvalho SB; Silva JV; Soares PM; Vale ML; Souza MH; Cunha FQ; Ribeiro RA
    Cancer Chemother Pharmacol; 2008 Apr; 61(5):775-84. PubMed ID: 17624531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Matrix metalloproteinases are possible mediators for the development of alimentary tract mucositis in the dark agouti rat.
    Al-Dasooqi N; Gibson RJ; Bowen JM; Logan RM; Stringer AM; Keefe DM
    Exp Biol Med (Maywood); 2010 Oct; 235(10):1244-56. PubMed ID: 20682600
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell adhesion molecules are altered during irinotecan-induced mucositis: a qualitative histopathological study.
    Al-Dasooqi N; Bowen J; Bennett C; Finnie J; Keefe D; Gibson R
    Support Care Cancer; 2017 Feb; 25(2):391-398. PubMed ID: 27650103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression analysis of multiple gastrointestinal regions reveals activation of common cell regulatory pathways following cytotoxic chemotherapy.
    Bowen JM; Gibson RJ; Tsykin A; Stringer AM; Logan RM; Keefe DM
    Int J Cancer; 2007 Oct; 121(8):1847-56. PubMed ID: 17594691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Faecal microflora and beta-glucuronidase expression are altered in an irinotecan-induced diarrhea model in rats.
    Stringer AM; Gibson RJ; Logan RM; Bowen JM; Yeoh AS; Keefe DM
    Cancer Biol Ther; 2008 Dec; 7(12):1919-25. PubMed ID: 18927500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and tolerability of velafermin (CG53135-05) in patients receiving high-dose chemotherapy and autologous peripheral blood stem cell transplant.
    Schuster MW; Shore TB; Harpel JG; Greenberg J; Jalilizeinali B; Possley S; Gerwien RW; Hahne W; Halvorsen YD
    Support Care Cancer; 2008 May; 16(5):477-83. PubMed ID: 17710442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.